Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds
Longevity Health Holdings entered a securities purchase agreement with Puritan Partners for up to $625,000 in gross proceeds through a series of 10% senior secured convertible notes, each issued with a 10% original issue discount. At the initial closing on August 31, 2026, the company received $375,000 in gross proceeds via a note due February 29, 2028, carrying $416,666.67 in original principal, 10% annual interest, and a $0.50 conversion price, secured by substantially all assets of the company and its subsidiaries. Two additional $125,000 tranches remain possible, but the second requires an effective resale registration statement and the third sits at Puritan's sole discretion.
Key figures
- Deal Value Usd
- 625000
- Maturity
- February 29, 2028
- Interest rate
- 10% per annum
- Conversion price
- 0.5
- Initial gross proceeds
- 375000
- Original issue discount
- 10%
- Additional tranche gross proceeds each
- 125000
- Additional tranches aggregate principal
- 277778
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.